Hyphens Pharma Company Announcements (1J5)

SGX Google Yahoo News TradingView

HYPHENS PHARMA INTL LIMITED (1J5) SGD 0.3 +0.00% +0.00

Portfolio Watchlist

All Financial Buy Back Insider Trading

2025-04-28

REPL::Annual General Meeting::Voluntary

2025-04-22

General Announcement::Responses to Substantial and Relevant Questions from Shareholders on Annual Report 2024

2025-04-21

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Change of Director's Interest - Dr Tan Kia King

2025-04-10

Cash Dividend/ Distribution::Mandatory

2025-04-10

Annual Reports and Related Documents::

2025-04-10

Annual General Meeting::Voluntary

2025-03-19

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Change of Director's Interest - Dr Tan Kia King

2025-03-11

General Announcement::Hyphens Pharma obtains exclusive rights to commercialise Metoject

2025-02-27

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Change of Director's Interest - Dr Tan Kia King

2025-02-27

General Announcement::Result Briefing FY2024

2025-02-25

Financial Statements and Related Announcement::Full Yearly Results

2024-12-12

Change - Announcement of Cessation::Cessation of General Manager of Pan-Malayan Pharmaceuticals Pte Ltd

2024-11-12

General Announcement::Quarterly Business Update for the third quarter and nine months ended 30 September 2024

2024-09-19

General Announcement::Hyphens Pharma Launches Ceradan Advanced Hand Balm

2024-08-27

General Announcement::Hyphens Pharma Wins Gold Award for Best Managed Board at Singapore Corporate Awards 2024

2024-08-16

General Announcement::Results Briefing 1H2024

2024-08-14

Financial Statements and Related Announcement::Half Yearly Results

2024-06-06

General Announcement::RESIGNATION OF MR. TIMOTHY CHEN, CEO OF DOCMED TECHNOLOGY AND PAN-MALAYAN PHARMACEUTICALS

2024-06-05

General Announcement::HYPHENS PHARMA LICENSES AMENALIEF FROM MARUHO FOR ASEAN

2024-05-24

General Announcement::Minutes of Annual General Meeting of the Company held on 25 April 2024

2024-05-14

General Announcement::BUSINESS UPDATE FOR THE FIRST QUARTER ENDED 31 MARCH 2024

2024-05-13

Share Buy Back - Daily Share Buy-Back Notice::Daily Share Buy-Back Notice

2024-04-25

REPL::Annual General Meeting::Voluntary

2024-04-23

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::CHANGE OF DIRECTOR'S INTEREST - MR CHAN KIAT

2024-04-19

REPL::Annual General Meeting::Voluntary

2024-04-08

Cash Dividend/ Distribution::Mandatory

2024-04-08

Annual General Meeting::Voluntary

2024-04-08

Annual Reports and Related Documents::

2024-04-02

Share Buy Back - Daily Share Buy-Back Notice::Daily Share Buy-Back Notice

2024-04-02

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::CHANGE OF DIRECTOR'S INTEREST - DR TAN KIA KING

2024-03-25

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::CHANGE OF DIRECTOR'S INTEREST - MR CHAN KIAT

2024-03-22

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::CHANGE OF DIRECTOR'S INTEREST - DR TAN KIA KING

2024-03-12

General Announcement::HYPHENS PHARMA LICENSES WYNZORA CREAM FOR ASEAN COUNTRIES FROM MC2 THERAPEUTICS

2024-03-06

General Announcement::RESULTS BRIEFING FY2023

2024-02-29

General Announcement::HYPHENS PHARMA'S CERADAN RANGE OF PRODUCTS TO ENTER MAJOR MIDDLE EAST MARKETS

2024-02-27

Financial Statements and Related Announcement::Full Yearly Results

2024-02-06

General Announcement::HYPHENS PHARMA PARTNERS 7-ELEVEN TO OFFER OCEAN HEALTH SUPPLEMENTS IN SINGAPORE

2023-12-08

Employee Stock Option/ Share Scheme::GRANT OF SHARE AWARDS PURSUANT TO THE HYPHENS SHARE PLAN

2023-11-09

General Announcement::QUARTERLY BUSINESS UPDATE FOR THE THIRD QUARTER AND NINE MONTHS ENDED 30 SEPTEMBER 2023

2023-11-08

Asset Acquisitions and Disposals::COMPLETION OF PROPOSED ACQUISITION OF THE TRANCHE 1 SALE SHARES OF 23% IN ARDENCE PHARMA SDN BHD

2023-10-19

General Announcement::ANALYST BRIEFING- ACQUISITION OF ARDENCE MALAYSIA

2023-10-17

Asset Acquisitions and Disposals::PROPOSED ACQUISITION OF 58% OF THE SHARE CAPITAL IN ARDENCE PHARMA SDN BHD OVER 3 TRANCHES

2023-08-30

General Announcement::NABOTA SUCCESSFULLY REGISTERED IN MALAYSIA

2023-08-17

General Announcement::RESULTS BRIEFING 1H 2023

2023-08-10

Cash Dividend/ Distribution::Mandatory

2023-08-10

Financial Statements and Related Announcement::Half Yearly Results

2023-07-19

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::CHANGE OF DIRECTOR'S INTEREST - DR TAN KIA KING

2023-07-19

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::CHANGE OF DIRECTOR'S INTEREST - MR LIM SEE WAH

2023-07-19

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)::CESSATION OF SUBSTANTIAL SHAREHOLDER'S INTEREST- MR TAN CHWEE CHOON

2023-07-19

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)::CHANGE OF SUBSTANTIAL SHAREHOLDER'S INTEREST - INOMED HOLDING PTE LTD

© 2025 Dividends.sg / More Countries

© Owned by Little White Pte. Ltd.